Resident Memory T Cells in Vitiligo
- Conditions
- Vitiligo
- Registration Number
- NCT05223738
- Lead Sponsor
- Kasr El Aini Hospital
- Brief Summary
This study aims to detect the presence and diversity of Tissue resident memory T cell populations in early and late cases of generalized non-segmental Vitiligo.
- Detailed Description
* Written informed consent obtained from every participant.
* Detailed history taking including onset, course, duration of the disease, aggravating factors and received medications
* VASI score assessed in every patient.
* Patients photographed, divided into two groups early \& late cases and 3 mm punch biopsies will be taken from perilesional and non lesional skin.
* Biopsies processed and stained for CD8 \& CD69 in cases of early group, \& late group and controls by immunofluorescence.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 29
-
- Patients with Generalized non-segmental Vitiligo ( lesions in more than one anatomical site ).
- Both genders.
- Early group: onset less than or equal 6 months.
- Late group: onset more than 6 months
- Localized or Segmental Vitiligo.
- Age < 14 years.
- Pregnant females
- Patient who received treatment of any type within the last 3 months for the late group.
- Patients with other skin diseases or immunosuppression
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Double CD8+ and CD69+ immunofluorescence 6months-1 year Number of Tissue resident Memory cells by double stained by CD8+ \&CD 69+ in early and late generalized non segmental vitiligo patients
CD69+ immunofluorescence 6months-1 year Number of Tissue resident Memory cells by positively stained by CD8+ in early and late generalized non segmental vitiligo patients
CD8+ immunofluorescence 6months-1 year Number of Tissue resident Memory cells by positively stained by CD8+ in early and late generalized non segmental vitiligo patients
VASI 6months-1 year Vitiligo Area and Severity index minimum 0 maximum 100, the larger the number the worse the condition
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kasr El Ainy University hospital
🇪🇬Cairo, Egypt